Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
FEBS Letters · 07.08.2026
DOI: 10.1002/1873-3468.70412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Letters, online erschienen am 07.08.2026. Verfasst von Daniel Cuervo-Zanatta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Austria. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hochschuljubiläumsstiftung der Stadt Wien, Secretaría de Estado de Ciencia, Tecnología e Innovación, Österreichische Akademie der Wissenschaften.
Abstract (Originalsprache)
Age‐related decline in neurovascular integrity is an increasingly recognized contributor to cognitive impairment and neurodegenerative vulnerability. A central feature is blood–brain barrier (BBB) dysfunction arising from endothelial senescence, altered barrier regulation, and chronic low‐grade inflammation. In parallel, aging remodels the gut microbiota, with reduced diversity, loss of short‐chain fatty acid‐producing commensals, and expansion of pro‐inflammatory taxa. Converging evidence indicates that age‐related shifts in the gut microbiota alter microbiome function and can modulate BBB physiology through microbial metabolites, immune‐endothelial signaling, and systemic metabolic pathways. These data position the gut–brain axis as an important, but not sole, modulator of neurovascular aging. Preclinical and emerging human data suggest that dysbiosis lowers the threshold for BBB dysfunction, and microbiome‐targeted interventions in experimental models can improve barrier‐relevant features. Notably, no human trial has yet demonstrated that microbiome modulation prevents or reverses BBB impairment using validated neuroimaging or fluid biomarkers. This review synthesizes mechanisms of microbiota‐BBB crosstalk in aging, distinguishes correlation from causation, and outlines translational opportunities and limitations of dietary, probiotic, and fecal microbiota‐based strategies for preserving neurovascular health in older adults.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Austria.
- Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Austria.
ORCID-Profile: Marietta Zille
Förderung
- Hochschuljubiläumsstiftung der Stadt Wien
- Secretaría de Estado de Ciencia, Tecnología e Innovación
- Österreichische Akademie der Wissenschaften
Zitieren
APA
Cuervo-Zanatta, D., Balasubramanian, H. B., Pasokh, A., & Zille, M. (2026). Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential. FEBS Letters. https://doi.org/10.1002/1873-3468.70412
Vancouver
Cuervo-Zanatta D, Balasubramanian HB, Pasokh A, Zille M. Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential. FEBS Letters. 2026. doi:10.1002/1873-3468.70412
BibTeX
@article{CuervoZanatta2026,
author = {Cuervo-Zanatta, Daniel and Balasubramanian, Hari Baskar and Pasokh, Amir and Zille, Marietta},
title = {Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential},
journal = {FEBS Letters},
year = {2026},
doi = {10.1002/1873-3468.70412}
}
EUVIMED